Sivik Global Healthcare’s Smith & Nephew SNN Stock Holding History

Sivik Global Healthcare’s Portfolio SNN Stock Details SNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.59M	Hold	50,000	–	–	1.21%	31
2026 Q1	$1.59M	Sell	50,000 -75,000	-60%	-$2.55M	1.21%	31
2025 Q4	$4.1M	Sell	125,000 -35,000	-22%	-$1.2M	1.19%	29
2025 Q3	$5.81M	Buy	160,000 +20,000	+14%	+$690K	1.69%	21
2025 Q2	$4.29M	Buy	140,000 +20,000	+17%	+$564K	1.17%	34
2025 Q1	$3.4M	Sell	120,000 -5,000	-4%	-$134K	1.84%	24
2024 Q4	$3.07M	Sell	125,000 -15,000	-11%	-$398K	1.62%	28
2024 Q3	$4.36M	Sell	140,000 -10,000	-7%	-$297K	1.85%	26
2024 Q2	$3.72M	Sell	150,000 -55,000	-27%	-$1.37M	1.34%	29
2024 Q1	$5.2M	Buy	205,000 +15,000	+8%	+$412K	1.22%	25
2023 Q4	$5.18M	Buy	+190,000	New	+$4.71M	2.17%	28
2021 Q4	–	Sell	-15,000	Closed	-$8.57M	–	55
2021 Q3	$8.57M	Buy	+15,000	New	+$591K	2.05%	15
2020 Q3	–	Sell	-120,000	Closed	-$11.6M	–	56
2020 Q2	$11.6M	Sell	120,000 -15,187	-11%	-$602K	3.86%	4
2020 Q1	$12.1M	Buy	135,187 +60,187	+80%	+$2.67M	4.79%	3
2019 Q4	$3.6M	Buy	+75,000	New	+$3.38M	1.34%	36
2019 Q3	–	Sell	-100,000	Closed	-$4.35M	–	56
2019 Q2	$4.35M	Sell	100,000 -10,000	-9%	-$414K	1.05%	26
2019 Q1	$4.41M	Buy	110,000 +34,000	+45%	+$1.31M	1.63%	29
2018 Q4	$2.84M	Buy	+76,000	New	+$2.73M	1.53%	32
2018 Q2	–	Sell	-100,000	Closed	-$3.81M	–	71
2018 Q1	$3.81M	Buy	100,000 +5,000	+5%	+$181K	1.78%	24
2017 Q4	$3.33M	Sell	95,000 -25,000	-21%	-$909K	1.23%	37
2017 Q3	$4.37M	Buy	120,000 +30,000	+33%	+$1.07M	1.49%	27
2017 Q2	$3.14M	Buy	90,000 +20,000	+29%	+$677K	1.15%	35
2017 Q1	$2.17M	Sell	70,000 -15,000	-18%	-$459K	1.01%	41
2016 Q4	$2.56M	Buy	85,000 +10,000	+13%	+$294K	1.22%	33
2016 Q3	$2.46M	Buy	+75,000	New	+$2.52M	1.24%	34
2016 Q1	–	Sell	-80,000	Closed	-$2.85M	–	65
2015 Q4	$2.85M	Buy	80,000 +30,000	+60%	+$1.03M	1.35%	34
2015 Q3	$1.75M	Sell	50,000 -63,628	-56%	-$2.27M	0.85%	50
2015 Q2	$3.86M	Sell	113,628 -26,372	-19%	-$916K	1.34%	28
2015 Q1	$4.78M	Buy	140,000 +1,300	+0.9%	+$46K	1.63%	25
2014 Q4	$5.1M	Buy	138,700 +1,200	+0.9%	+$40.4K	2.06%	16
2014 Q3	$4.63M	Buy	137,500 +25,000	+22%	+$872K	2.1%	14
2014 Q2	$4.02M	Hold	112,500	–	–	2.03%	22
2014 Q1	$3.44M	Buy	112,500 +12,500	+13%	+$378K	2.15%	11
2013 Q4	$2.87M	Buy	+100,000	New	+$2.64M	2.04%	21

Other funds holding SNN

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

CCM

Causeway Capital Management Los Angeles, California $9.24B AUM 21.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

TAM

Todd Asset Management Louisville, Kentucky $5.63B AUM 45.28% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Sivik Global Healthcare's SNN Position: Q2 2026 in Review

Sivik Global Healthcare held its Smith & Nephew (SNN) position steady in Q2 2026 at 50,000 shares worth $1.59M. The position accounts for 1.21% of the portfolio, ranked #31.

Sivik Global Healthcare first reported a position in SNN in Q4 2013 and has held it in 34 quarters since. The position peaked at $12.1M in Q1 2020. 294 funds tracked by Wall St. Rank hold SNN as of Q2 2026.

Sivik Global Healthcare held 50,000 shares of Smith & Nephew worth $1.59M as of Q2 2026.
Sivik Global Healthcare left its Smith & Nephew share count unchanged in Q2 2026.
Smith & Nephew made up 1.21% of Sivik Global Healthcare's portfolio in Q2 2026, its #31 holding.
Sivik Global Healthcare first reported a position in Smith & Nephew in Q4 2013 and has held it in 34 quarters since.
Sivik Global Healthcare's Smith & Nephew position peaked at $12.1M in Q1 2020.
294 funds tracked by Wall St. Rank held Smith & Nephew as of Q2 2026.

Based on Sivik Global Healthcare's 13F filing for Q2 2026, filed 20 Jul 2026.